DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Dziba JM, Ain KB.
Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro.
J Clin Endocrinol Metab 2004; 89: 2127-2135
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.